Eli Lilly | LLY - Capitalización De Mercado

Precio De Mercado
910.55
Cambio Diario
3.85 0.42%
Mensual
-12.63%
Anual
5.28%
Q1 Expectativa
879.50




Capitalización De Mercado Cambio Fecha
AbbVie USD 403.83B 5.2B 2025-12
Abbott USD 217.86B 15.25B 2025-12
ALKERMES USD 4.47B 146M 2026-03
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 220.14B 68B 2026-03
Baxter International USD 9.82B 1.87B 2025-12
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Coherus Biosciences USD 183M 11M 2026-03
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Glaxosmithkline GBP 107.89B 7.96B 2026-03
J&J USD 500.24B 67.44B 2025-12
Medtronic USD 105.43B 23.9B 2026-03
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 240.48B 51.73B 2026-03
Novartis USD 303.66B 40.58B 2026-03
Novo Nordisk A/S DKK 1.45T 86.62B 2025-12
Perrigo USD 1.4B 520M 2026-03
Pfizer USD 153.96B 12.4B 2026-03
Phibro Animal Health USD 2B 490M 2026-03
Prestige Brands USD 2.97B 105M 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Sanofi EUR 117.34B 2.45B 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Zoetis USD 55.45B 9.4B 2025-12